Is It Time to Replace Vancomycin in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections?
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is It Time to Replace Vancomycin in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections?
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume 56, Issue 12, Pages 1779-1788
Publisher
Oxford University Press (OUP)
Online
2013-03-20
DOI
10.1093/cid/cit178
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia
- (2013) Natasha E. Holmes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Implementation of an Antimicrobial Stewardship Pathway with Daptomycin for Optimal Treatment of Methicillin-ResistantStaphylococcus aureusBacteremia
- (2013) Ravina Kullar et al. PHARMACOTHERAPY
- Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter
- (2012) S. J. van Hal et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Reduced Vancomycin Susceptibility on Clinical and Economic Outcomes in Staphylococcus aureus Bacteremia
- (2012) Jennifer H. Han et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Questionable Superiority of Linezolid for Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: Watch Where You Step
- (2012) T. Lahey CLINICAL INFECTIOUS DISEASES
- Linezolid for the Treatment of Nosocomial Pneumonia Due to Methicillin-Resistant Staphylococcus aureus
- (2012) M. Wolff et al. CLINICAL INFECTIOUS DISEASES
- Methicillin-Resistant Staphylococcus aureus (MRSA) Staphylococcal Cassette Chromosome mec Genotype Effects Outcomes of Patients With Healthcare-Associated MRSA Bacteremia Independently of Vancomycin Minimum Inhibitory Concentration
- (2012) S.-Y. Chen et al. CLINICAL INFECTIOUS DISEASES
- The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis
- (2012) S. J. van Hal et al. CLINICAL INFECTIOUS DISEASES
- Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study
- (2012) R. G. Wunderink et al. CLINICAL INFECTIOUS DISEASES
- Predictors of Mortality in Staphylococcus aureus Bacteremia
- (2012) S. J. van Hal et al. CLINICAL MICROBIOLOGY REVIEWS
- High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia
- (2012) Yu Mi Wi et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Vancomycin MICs do not predict the outcome of methicillin-resistant Staphylococcus aureus bloodstream infections in correctly treated patients
- (2012) L. Rojas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy
- (2012) T. T. Ho et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The emerging problem of linezolid-resistant Staphylococcus
- (2012) B. Gu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients
- (2012) Jennifer C. Lin et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Serine/Threonine Phosphatase Stp1 Contributes to Reduced Susceptibility to Vancomycin and Virulence in Staphylococcus aureus
- (2012) David R. Cameron et al. JOURNAL OF INFECTIOUS DISEASES
- Impact of vancomycin MIC creep on patients with methicillin-resistant Staphylococcus aureus bacteremia
- (2012) Yen-Cheng Yeh et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Characteristics and Outcomes of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections in Patients with Cancer Treated with Vancomycin: 9-Year Experience at a Comprehensive Cancer Center
- (2012) S. N. Mahajan et al. ONCOLOGIST
- Vancomycin AUC24/MIC Ratio in Patients with Complicated Bacteremia and Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus and Its Association with Attributable Mortality during Hospitalization
- (2011) Jack Brown et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Interface Between Antibiotic Resistance and Virulence in Staphylococcus aureus and Its Impact Upon Clinical Outcomes
- (2011) D. R. Cameron et al. CLINICAL INFECTIOUS DISEASES
- Vancomycin: We Can't Get There From Here
- (2011) N. Patel et al. CLINICAL INFECTIOUS DISEASES
- Daptomycin Versus Vancomycin for Bloodstream Infections Due to Methicillin-Resistant Staphylococcus aureus With a High Vancomycin Minimum Inhibitory Concentration: A Case-Control Study
- (2011) C. L. Moore et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets
- (2011) R. Kullar et al. CLINICAL INFECTIOUS DISEASES
- Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007–2009 study
- (2011) Heather J. Adam et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Methicillin-resistant Staphylococcus aureus vancomycin susceptibility testing: methodology correlations, temporal trends and clonal patterns
- (2011) S. J. van Hal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia
- (2011) C. J. Walraven et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Is Vancomycin MIC "Creep" Method Dependent? Analysis of Methicillin-Resistant Staphylococcus aureus Susceptibility Trends in Blood Isolates from North East Scotland from 2006 to 2010
- (2011) B. Edwards et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Performance of Various Testing Methodologies for Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus in Bloodstream Isolates
- (2011) S. J. van Hal et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
- (2011) Natasha E. Holmes et al. JOURNAL OF INFECTIOUS DISEASES
- Epidemiology of Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infection
- (2011) Oriol Gasch et al. MEDICINE
- Vancomycin Heteroresistance Is Associated with Reduced Mortality in ST239 Methicillin-Resistant Staphylococcus aureus Blood Stream Infections
- (2011) Sebastiaan J. van Hal et al. PLoS One
- Vancomycin MIC Susceptibility Testing of Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Isolates: A Comparison Between Etest® and an Automated Testing Method
- (2011) Christopher M. Bland et al. SOUTHERN MEDICAL JOURNAL
- Systematic Review and Meta-Analysis of the Significance of Heterogeneous Vancomycin-IntermediateStaphylococcus aureusIsolates
- (2010) Sebastiaan J. van Hal et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia
- (2010) Elizabeth A. Neuner et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient—a review of the literature
- (2010) S. J. van Hal et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy
- (2010) Annie Wong-Beringer et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinical Outbreak of Linezolid-Resistant Staphylococcus aureus in an Intensive Care Unit
- (2010) Miguel Sánchez García JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vancomycin Susceptibility Trends and Prevalence of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus in Clinical Methicillin-Resistant S. aureus Isolates
- (2010) A. M. Pitz et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Detection and Characterization of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates in Canada: Results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006
- (2009) H. J. Adam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine U.S. Medical Centers from 2002 to 2006
- (2009) H. S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Susceptible MRSA
- (2009) K. C. Horne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health‐System Pharmacists, and the Society of Infectious Diseases Pharmacists
- (2009) Michael J. Rybak et al. CLINICAL INFECTIOUS DISEASES
- Relationship between Initial Vancomycin Concentration‐Time Profile and Nephrotoxicity among Hospitalized Patients
- (2009) Thomas P. Lodise et al. CLINICAL INFECTIOUS DISEASES
- Vancomycin MIC plus Heteroresistance and Outcome of Methicillin-Resistant Staphylococcus aureus Bacteremia: Trends over 11 Years
- (2009) A. C. Musta et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong
- (2009) Pak-Leung Ho et al. JOURNAL OF INFECTION
- Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions
- (2009) Pamela A Moise et al. LANCET INFECTIOUS DISEASES
- Increasing Antibiotic Resistance among Methicillin‐ResistantStaphylococcus aureusStrains
- (2008) George Sakoulas et al. CLINICAL INFECTIOUS DISEASES
- High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia
- (2008) M. Sharma et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage
- (2008) J.-I. Alos et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Characterization of Vancomycin-Heteroresistant Staphylococcus aureus from the Metropolitan Area of Detroit, Michigan, over a 22-Year Period (1986 to 2007)
- (2008) M. J. Rybak et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
- (2007) A. Soriano et al. CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More